We help early-stage biotech teams apply AI across R&D—before clinical data exists.

Our platforms and services support critical early decisions through:

• Patent freedom-to-operate (FTO) analysis
• AI-driven target identification and drug discovery
• Competitive pipeline intelligence, tracking who is working on which assets, diseases, and development stages
• Data and ETL automation to replace heavy, manual bioinformatics workflows
• Knowledge graphs and agentic AI systems to enable faster, more informed R&D decision-making

Our team is built by PhD-level experts in biotechnology and artificial intelligence, combining deep scientific insight with advanced AI engineering.